Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Job Responsibilities
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
1056
result was found. Results that relate to
CT
Research progress on the role of microRNA in epithelial-mesenchymal transition of colorectal cancer
Published on
New Medicine
2026,36(1):103-109.
3236 times
429 times
ZHANG Tao
LI Huilong
FENG Jing
CHEN Miao
Colore
ct
al cancer
Epithelial-mesenchymal transition
MicroRNA
Drug resistance
Natural compound
Details
A case report of vascular stent implantation for the treatment of hepatic venous outflow obstruction after liver transplantation and literature review
Published on
New Medicine
2026,36(1):110-115.
3107 times
360 times
NING Yuxiang
ZHOU Shujun
GAO Zhuo
WANG Yanfeng
Liver transplantation
Hepatic venous outflow obstru
ct
ion
Interventional therapy
Details
Effects of colchicine on high-sensitivity C-reactive protein and other inflammatory markers in patients with coronary atherosclerotic heart disease: a Meta-analysis
Published on
Chinese Journal of Pharmacoepidemiology
2026,35(2):182-191.
1644 times
387 times
HE Shuangcheng
LIU Yuwei
TAN Gao
YUAN Yu
LIU Tao
LIU Xiaoli
Colchicine
Coronary atherosclerotic heart disease
High-sensitivity C-rea
ct
ive protein
Inflammatory markers
Meta-analysis
Details
Mepolizumab for refractory chronic rhinosinusitis with nasal polyps: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2026,35(2):192-199.
1387 times
267 times
GU Shilong
ZHANG Wenjing
GUO Hao
Mepolizumab
Refra
ct
ory chronic rhinosinusitis with nasal polyps
Effe
ct
iveness
safety
Cost-effe
ct
iveness
Details
Machine learning for predicting adverse drug events in polypharmacy: a review of methods and case studies
Published on
Chinese Journal of Pharmacoepidemiology
2026,35(3):327-335.
1360 times
411 times
LONG Yujun
LIU Jianzhao
YANG Zhirong
Polypharmacy
Adverse drug events
Machine learning
Graph convolutional neural network
Predi
ct
ion model
Details
Applicability challenges and optimization strategies of guideline recommendations in multimorbidity management
Published on
Chinese Journal of Pharmacoepidemiology
2026,35(3):336-345.
565 times
180 times
ZHU Shuqiong
TALIFU Paerwenayi
RUAN Siyuan
GAO Feng
YOU Liangzhen
WANG Yongbo
YAN Siyu
HUANG Qiao
REN Xiangying
JIN Yinghui
Multimorbidity
Clinical pra
ct
ice guideline
Recommendation
Real-world evidence
Artificial intelligence
Details
Guide on Methodological Standards in Pharmacoepidemiology (2nd edition) and their series interpretation (14): research designs and case studies of target trial emulation
Published on
Chinese Journal of Pharmacoepidemiology
2026,35(2):121-132.
1595 times
373 times
ZHAO Houyu
CHENG Yinchu
SUN Feng
ZHAN Siyan
Target trial emulation
Pharmacoepidemiology
Methodology
Guidelines
A
ct
ive comparator new-user design
Sequential trial
Clone-censor-weight
Details
Effects of denosumab versus zoledronic acid on bone formation markers and cancer pain intensity in patients with non-small cell lung cancer and bone metastases: a retrospective study
Published on
Chinese Journal of Pharmacoepidemiology
2026,35(2):140-146.
1263 times
326 times
HU Ran
LI Wei
LI Yonghong
CHEN Cong
WAN Chao
Denosumab
Zoledronic acid
Non-small cell lung cancer
Bone metastases
Cancer pain
Bone formation markers
Retrospe
ct
ive study
Details
Antimicrobial treatment practices for an elderly patient with acute exacerbation of chronic renal insufficiency complicated with severe infection
Published on
Chinese Journal of Pharmacoepidemiology
2026,35(2):209-214.
1243 times
298 times
XING Baiqian
CHEN Yalei
WANG Genzhu
WANG Xiaoying
LU Nianfang
Chronic renal insufficiency
Severe infe
ct
ion
Pneumocystis jirovecii
Staphylococcus aureus
Pharmaceutical care
Details
Acute allergic reaction induced by efbemalenograstim alfa: a case report
Published on
Chinese Journal of Pharmacoepidemiology
2026,35(2):232-236.
1015 times
234 times
ZENG Xin
WANG Yaqin
HUANG Yaxuan
LI Juan
Efbemalenograstim alfa
Allergy
mNeutropenia
Adverse drug rea
ct
ion
Details
Network pharmacological exploration of the mechanism of Scutellaria baicalensis antigenic primary biliary cholangitis
Published on
Frontiers in Pharmaceutical Sciences
2026,30(2):181-189.
1239 times
282 times
WANG Chunxia
ZHAO Zan
GUO Qinghong
Primary biliary cholangitis
Scutellaria baicalensis
Network pharmacology
Molecular docking
Molecular dynamics simulation
Signaling pathways
GO fun
ct
ion analysis
KEGG pathway enrichment analysis
Details
Exploring the mechanism of action of Aconitum Heterophyllum in treating gout based on network pharmacology and molecular modeling
Published on
Frontiers in Pharmaceutical Sciences
2026,30(2):190-200.
1270 times
258 times
ZHANG Ruirui
CHEN Quansheng
ZHANG Bingyin
WU Yuwen
YAN Caifeng
Aconitum Heterophyllum
Gout
Network pharmacology
Molecular docking
Molecular dynamics simulation
A
ct
ive ingredients
Signaling pathways
Protein-protein intera
ct
ions
Details
Study on the preparation process and in vitro release of vitamin B2 sustained-release tablets
Published on
Frontiers in Pharmaceutical Sciences
2026,30(2):219-225.
1177 times
256 times
LIU Yinyuan
DONG Xiaofen
HUANG Yanqiao
WANG Hongxia
WU Di
Vitamin B2
Sustained-release tablets
Hydroxypropyl methylcellulose
Microcrystalline cellulose
La
ct
ose
Preparation process
In vitro release rate
Details
Characterization of different crystal forms of albendazole and comparative impact on tablet dissolution behavior
Published on
Frontiers in Pharmaceutical Sciences
2026,30(2):226-232.
986 times
214 times
SUN Hailing
BAO Shi
TAO Yi
CHEN Leiling
SUN Ying
LIU Chenxi
Albendazole
Crystal form
X-ray diffra
ct
ion
Differential scanning calorimetry
Field emission scanning ele
ct
ron
Flow-cell dissolution method
Dissolution rate
Details
Research on the identification and standard improvement of talc medicinal materials
Published on
Frontiers in Pharmaceutical Sciences
2026,30(2):233-239.
1012 times
234 times
JIN Wanjun
ZHANG Mingtong
NI Lin
Talc
Asbestos
Chinese Pharmacopoeia
Identification
X-ray diffra
ct
ion
Method validation
Standard improvement
Quality control
Details
上一页
1
2
62
63
64
65
66
67
68
69
70
71
下一页